Latest Executive Transitions News

Page 2 of 2
Vitrafy Life Sciences announces a leadership change with CEO Kate Munnings retiring and co-founder Brent Owens stepping up to lead the company’s next growth phase.
Ada Torres
Ada Torres
5 Aug 2025
ClearVue Technologies announces key leadership changes with COO Douglas Hunt stepping in as interim CEO, alongside two new board appointments, signaling a strategic push to accelerate growth and innovation.
Sophie Babbage
Sophie Babbage
8 July 2025
ParagonCare appoints Carmen Riley as CEO effective July 1, 2025, with a planned transition period under outgoing CEO David Collins to complete integration and pursue M&A opportunities.
Ada Torres
Ada Torres
25 June 2025
Patrys Limited has formalized the redundancy of CEO Dr James Campbell, with a $535,877 payout partly converted into shares pending shareholder approval. Dr Campbell will continue as a non-executive director.
Ada Torres
Ada Torres
17 June 2025
Peet Limited has appointed its long-serving CFO Brett Fullarton as Interim CEO effective immediately, ahead of the planned departure of CEO Brendan Gore on 1 July 2025. This move aims to ensure a smooth leadership transition while a permanent CEO search is underway.
Eva Park
Eva Park
13 June 2025
Peet Limited announces the planned departure of long-serving CEO Brendan Gore, with CFO Brett Fullarton stepping in as interim leader. The company also signals a strategic review amid shareholder requests.
Eva Park
Eva Park
15 May 2025
Westpac Banking Corporation reported a modest 1% decline in net profit to AUD 3.317 billion for the six months ended March 2025, maintaining its interim dividend and advancing key digital and sustainability initiatives.
Claire Turing
Claire Turing
5 May 2025
Earth’s Energy Limited reports progress on South Australian geothermal projects with promising feasibility study results, while navigating executive transitions and shareholder governance challenges.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Anatara Lifesciences reports mixed results from its Phase II GaRP-IBS trial, missing the primary efficacy target but showing significant improvements in anxiety and patient-reported relief, while advancing its anti-obesity pre-clinical program.
Ada Torres
Ada Torres
30 Apr 2025
Trinex Minerals corrects its quarterly report and reveals promising exploration progress at the Dudley Lithium Project, while managing a lean cash position and leadership changes.
Maxwell Dee
Maxwell Dee
31 Jan 2025